SB941

Pharmaceutical products; requiring manufacturers to publish certain list of ingredients; providing administrative, civil, and criminal penalties and remedies. Effective date.

Introduced·2/3/25
Int Text

Oklahoma SB941 mandates pharmaceutical manufacturers to disclose detailed ingredient lists and faces penalties for noncompliance.

Oklahoma SB941 requires manufacturers of pharmaceutical products to publish a complete list of all ingredients, including chemical and common names, origins, and purposes. Noncompliance results in fines, prohibition of operations, and criminal liability. Civil remedies include private right to action, injunctive relief, and whistleblower protections. The State Board of Pharmacy will establish a reporting system for violations. The act preempts certain rulemaking and retains exclusive rule-making authority for enforcement.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health and Human Services Committee
Next
Committee decision

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Feb 4, 2025

Senate

Second Reading referred to Health and Human Services

Feb 3, 2025

Senate

First Reading

Feb 3, 2025

Senate

Authored by Senator Deevers